retatrutide clinical trials retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Phase 3: TRIUMPH Program

Brand-name drugs typically cost more than generics

Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)

If you were seriously injured after taking a GLP-1 medication, you may be able to seek compensation for the losses caused by your injury

These findings underscore the varying psychiatric risks associated with different GLP-1 RAs and the importance of individualized patient assessment in clinical practice